Revance Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Revance Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2013 to Q3 2024.
  • Revance Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 190M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 190M 0 0% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 190M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 190M 0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 190M 0 0% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 190M 0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 190M 0 0% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 190M 0 0% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 190M 0 0% Dec 31, 2022 10-K 2024-02-28
Q3 2022 190M 0 0% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 190M 0 0% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 190M +95M +100% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 190M +95M +100% Dec 31, 2021 10-K 2023-02-28
Q3 2021 190M +95M +100% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 190M +95M +100% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 95M 0 0% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 95M 0 0% Dec 31, 2020 10-K 2022-02-28
Q3 2020 95M 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 95M 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 95M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 95M 0 0% Dec 31, 2019 10-K 2021-02-25
Q3 2019 95M 0 0% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 95M 0 0% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 95M 0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 95M 0 0% Dec 31, 2018 10-K 2020-02-26
Q3 2018 95M 0 0% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 95M 0 0% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 95M 0 0% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 95M 0 0% Dec 31, 2017 10-K 2019-02-28
Q3 2017 95M 0 0% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 95M 0 0% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 95M 0 0% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 95M 0 0% Dec 31, 2016 10-K 2018-03-02
Q3 2016 95M 0 0% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 95M 0 0% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 95M 0 0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 95M 0 0% Dec 31, 2015 10-K 2017-02-28
Q3 2015 95M 0 0% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 95M 0 0% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 95M 0 0% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 95M -129M -57.6% Dec 31, 2014 10-K 2016-03-04
Q3 2014 95M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 95M Jun 30, 2014 10-Q 2014-08-13
Q1 2014 95M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 224M Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.